开放活体供肝右半肝切除与肝癌右半肝切除的教科书结局:686例基准再定义
单中心2010–2020年前瞻性数据库比较开放活体供肝右半肝切除(RH)与开放右半肝切除治疗癌症的教科书结局(TO)。686例中供肝者TO达92.2%、癌症病例53.7%;供肝者术中出血量增加及癌症病例男性、肿瘤大小、术中出血量增加与TO失败相关。
要点
- 开放活体供肝RH的TO率超90%,可作为该术式“最佳可实现”基准。
- 开放RH治疗癌症的TO率约半数,与供肝者存在明显差距。
- 供肝者术中出血量增加、癌症病例男性/肿瘤大小/术中出血量增加与TO失败相关。
核心结论
- 开放活体供肝RH的TO率超过90%,开放RH治疗癌症的TO率约一半,前者可作为后者“真实世界”TO的新基准。
研究设计与样本
- 单中心前瞻性数据库回顾性比较2010–2020年开放活体供肝RH与开放RH治疗癌症的TO率。
- 共纳入686例RH患者,其中活体供肝371例、癌症病例315例。
- TO定义为同时满足7项指标:无围术期输血、无重大术后并发症、无显著胆漏、无计划外转入ICU、无30天死亡、无30天再入院、癌症病例无R1切缘。
主要发现
- 活体供肝RH的TO率为92.2%,癌症RH的TO率为53.7%。
- 活体供肝者倾向更年轻、更健康、更瘦。
- 供肝者术中出血量增加与TO失败相关;癌症病例中男性、肿瘤大小、术中出血量增加与TO失败相关。
关键数值与推荐
- TO需同时满足7项指标:无围术期输血、无重大术后并发症、无显著胆漏、无计划外转入ICU、无30天死亡、无30天再入院、癌症病例无R1切缘。
- 活体供肝RH的TO率为92.2%(371例中),癌症RH的TO率为53.7%(315例中)。
临床怎么用
- 可将开放活体供肝RH的TO率作为开放RH的“最佳可实现”基准,用于评估癌症RH的质量。
- 关注术中出血量以降低TO失败风险,癌症病例还需关注男性与肿瘤大小因素。
局限性
- 单中心回顾性研究,结果外推需谨慎。
- 活体供肝者与癌症病例基线特征(年龄、健康状态、体重)存在差异,可能影响TO比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare textbook outcomes (TO) of open live donor right hepatectomy (RH) versus open right hepatic lobectomy for cancer in a single Western center and to identify clinical factors associated with failure to achieve a TO. BACKGROUND: TO, a composite quality measure that captures multiple aspects of perioperative care, has not been thoroughly studied in open RH. We hypothesized that TO rates after RH for live donor transplant could represent the "best-achievable" results of this operation and could serve as the benchmark for RH performed for an oncologic indication. METHODS: A prospective database was reviewed to compare TO rates after RH for live donor purposes versus RH for cancer at a single center from 2010 to 2020. A TO was defined as achieving 7 metrics: no perioperative transfusion, no major postoperative complications, no significant bile leak, no unplanned transfer to the ICU, no 30-day mortality, no 30-day readmission, and no R1 margins for cancer cases. RESULTS: Among 686 RH patients (371 live donor and 315 cancer cases), a TO was achieved in 92.2% of RH donors and 53.7% of RH cancer cases. Live donor patients tended to be younger, healthier, and thinner. Among donors, increased intraoperative blood loss, and in cancer cases, male sex, tumor size, and increased intraoperative blood loss were associated with TO failure. CONCLUSIONS: A TO can be achieved in over 90% of patients undergoing living donor RH and in approximately half of RH cancer cases. These metrics represent a new benchmark for "real-world" TO after open RH.
引用
- Dogeas E, Geller DA, Tohme S, et al. Textbook Outcomes After Open Live Donor Right Hepatectomy and Open Right Hepatic Lobectomy for Cancer in 686 patients: Redefining the Benchmark. Ann Surg. 2022. PMID: 36321444. doi:10.1097/SLA.0000000000005749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。